Advertisement

Reactions Weekly

, Volume 1697, Issue 1, pp 384–384 | Cite as

Vedolizumab

Skin lesions: case report
Case report
  • 20 Downloads

Reference

  1. Chaparro M, et al. Long-term effectiveness and safety of vedolizumab (VDZ) in inflammatory bowel disease (IBD): Results from the Spanish ENEIDA Registry. Journal of Crohn's and Colitis 12 (Suppl. 1): S447-S448, Feb 2018 [abstract] -Spain Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations